Heart Test Laboratories, Inc. (HSCS) Stock Statistics & Valuation Metrics

Heart Test Laboratories, Inc. has a market cap or net worth of $7.32M. The enterprise value is -$3.39B.

Heart Test Laboratories, Inc. has 3,184,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Heart Test Laboratories, Inc.’s return on equity (ROE) is -42.72 and return on invested capital (ROIC) is -261.80%.

The current PE Ratio of Heart Test Laboratories, Inc. is ―. Heart Test Laboratories, Inc.’s PEG ratio is 0.00749.

In the last 12 months, Heart Test Laboratories, Inc. had revenue of 4.35K and earned -8.77M in profits. Earnings per share was -9.34.

In the last 12 months, operating cash flow was -5.75B and capital expenditures -3.56M, giving a free cash flow of -5.76B billion.

Heart Test Laboratories, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Heart Test Laboratories, Inc. upcoming earnings date is Jul 22, 2026, After Close (Confirmed).

Heart Test Laboratories, Inc. as a current ratio of 0.59, with Debt / Equity ratio of 145.81%

In the past 12 months, Heart Test Laboratories, Inc. has paid 0.00 in taxes.

Heart Test Laboratories, Inc. EV to EBITDA ratio is -0.64, with an EV/FCF ratio of -0.70.

Heart Test Laboratories, Inc. has $3.40B in cash and marketable securities with $3.87M in debt, giving a net cash position of $3.39B billion.

Gross margin is -1060.25%, with operating margin of -192013.13%, and net profit margin of -201499.52%.

The average price target for Heart Test Laboratories, Inc. is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy